Codexis to Announce First Quarter 2010 Financial Results May 26, 2010
Font : A-A+
REDWOOD CITY, Calif., May 6 Codexis, Inc. (Nasdaq: CDXS) today announced the company will host a conference call and webcast on Wednesday, May 26, 2010 at 4:30 p.m. Eastern Time to discuss its first quarter financial results for the period ended March 31, 2010. The call and webcast will follow the release of first quarter financial results after market close. A recorded version of the call will be available approximately one hour after the call at the Investor Relations section of the company's website, www.codexis.com.
Codexis, Inc. is a leading provider of optimized biocatalysts that make existing industrial processes faster, cleaner and more efficient than current methods and have the potential to make new industrial processes possible at commercial scale. Codexis has commercialized its biocatalysts in the pharmaceutical industry and is developing biocatalysts for use in producing advanced biofuels under a multi-year research and development collaboration. The company is also using its technology platform to pursue biocatalyst-enabled solutions in other bioindustrial markets, including carbon management, water treatment and chemicals.
Codexis' first quarter 2010 financial results What: conference call and webcast Date: Wednesday, May 26, 2010 Time: 4:30 p.m. ET Live Call: US: 866-783-2145 International: 857-350-1604 Passcode: 56829308 Replay: US: 888-286-8010 International: 617-801-6888 Passcode: 94161862 The webcast will be archived for up to thirty days.
SOURCE Codexis, Inc.
Post your Comments
Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer